PepGen to Participate in the Bank of America Securities 2023 Healthcare Conference
2023年5月4日 - 9:00PM
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company
advancing the next generation of oligonucleotide therapies with the
goal of transforming the treatment of severe neuromuscular and
neurological diseases, today announced that James McArthur,
Ph.D., President and CEO of PepGen will present at the Bank of
America Securities 2023 Healthcare Conference on Thursday, May 11th
at 12:20pm EDT in Las Vegas, Nevada.
The event will be webcast live under the Events &
Presentations section of the Investor
Relations section of PepGen’s website. A replay of the event
will be archived for one year.
About PepGenPepGen Inc. is a clinical-stage
biotechnology company advancing the next-generation of
oligonucleotide therapies with the goal of transforming the
treatment of severe neuromuscular and neurological diseases.
PepGen’s Enhanced Delivery Oligonucleotide, or EDO, platform is
founded on over a decade of research and development and leverages
cell-penetrating peptides to improve the uptake and activity of
conjugated oligonucleotide therapeutics. Using these EDO peptides,
we are generating a pipeline of oligonucleotide therapeutic
candidates that target the root cause of serious diseases.
Investor ContactLaurence WattsGilmartin
GroupLaurence@gilmartinir.com
Media ContactSarah SuttonArgot
PartnersPepGen@argotpartners.com
PepGen (NASDAQ:PEPG)
過去 株価チャート
から 4 2024 まで 5 2024
PepGen (NASDAQ:PEPG)
過去 株価チャート
から 5 2023 まで 5 2024